Vitamin E and oxidative stress in the heart of the cardiomyopathic Syrian hamster

Free Radical Biology and Medicine

Volumn 24, Issue 2, 1998, Pages 252-258

  Li, Ren Ke ^a   Sole, Michael J ^a   Mickle, Donald A G ^a   Schimmer, Joshua ^a   Goldstein, David ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Alpha tocopherol; Cardiomyopathy; Free radical; Glutathione peroxidase; Heart failure; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CATALASE; FREE RADICAL; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADOLESCENT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLUTATHIONE METABOLISM; HEART DILATATION; HEART FAILURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; SYRIAN HAMSTER; VITAMIN METABOLISM;

ALPHA-TOCOPHEROL; ANIMALS; CARDIOMYOPATHY, DILATED; CATALASE; CRICETINAE; GLUTATHIONE PEROXIDASE; MALE; MESOCRICETUS; MYOCARDIUM; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEINS; SUPEROXIDE DISMUTASE; VITAMIN E;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 0031974173     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00224-4     Document Type: Article

References (36)

1. Dhalla A. K., Singal P. K. Antioxidant changes in hypertrophied and failing guinea pig hearts. Am. J. Physiol. 266:(Heart Circ. Physiol. 35):1994;H1280-H1285.
2. Dhalla A. K., Hill M. F., Singal P. K. Role of oxidative stress in transition of hypertrophy to heart failure. J. Am. Coll. Cardiol. 28:1996;506-514.
3. Hill M. F., Singal P. K. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am. J. Pathol. 148:1996;291-300.
4. Prasad K., Gupta J. B., Lee J. K. P., Mantha S. V., Bharadwaj B. Oxidative stress as a mechanism of cardiac failure in chronic volume overload in canine model. J. Mol. Cell. Cardiol. 28:1996;375-385.
5. Bishop S. P., Sole M. J., Tilley L. P. Cardiomyopathies. Andrews E. J., Ward B. C., Altman N. H. Spontaneous Animal Models of Human Disease. 1:1979;59-64 Academic Press, Toronto.
6. Sakanashi T., Sako S., Nozuhara A., Adachi K., Okamoto T., Koga Y., Toshima H. Vitamin E deficiency has a pathological role in myocytolysis in cardiomyopathic Syrian hamster (Bio 14.6). Biochem. Biophys. Res. Comm. 181:1991;145-150.
7. Fukuchi T., Kobayashi A., Kaneko M., Ichiyama A., Yamazaki N. Possible involvement of free radicals and antioxidants in the early stages of the development of cardiomyopathy in Bio 14.6 Syrian Hamster. Jpn. Heart J. 32:1991;655-666.
8. L'Abbe M. R., Fischer P. W. F. An automated method for the determination of Cu, Zn-superoxide dismutase in plasma and erythrocytes using an ABA-200 discrete analyzer. Clin. Biochem. 19:1986;175-178.
9. Cohen G., Dembiec D., Marcus J. Measurement of catalase activity in tissue extracts. Anal. Biochem. 34:1970;30-38.
10. Doroshow J. H., Locker G. Y., Myers C. E. Enzymatic defenses of the mouse heart against reactive oxygen radicals. J. Clin. Invest. 65:1980;128-135.
11. Ingold K. U., Burton G. W., Foster D. O., Hughes L., Lindsay D. A., Webb A. Biokinetics and discrimination between dietary RRR- and SRR-alpha-tocopherols in the male rat. Lipids. 22:1987;163-172.
12. Daly P. A., Sole M. J. Myocardial catecholamines and the pathophysiology of heart failure. Circulation. 82:(suppl I):1990;I-35-I-43.
13. Singal, P. K.; Kapur, N.; Dhillon, K. S.; Beamish, R. E.; Dhalla, N. S. Role of free radicals in catecholamine-induced cardiomyopathy. Can. J. Physiol. Pharmacol. 60:1490-1397; 1982.
14. Mann D. L., Kent R. L., Parsons B., Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 85:1992;790-804.
15. Singal B. K., Beamish R. E., Dhalla N. S. Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv. Exp. Med. Biol. 161:1983;391-401.
16. Yates J. C., Beamish R. E., Dhalla N. S. Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy. Am. Heart. J. 102:1981;210-220.
17. Flitter W. D. Free radicals and myocardial reperfusion injury. Br. Med. Bull. 49:1993;545-555.
18. Factor S. M., Minase T., Cho S., Dominita R., Sonnenblick E. H. Microvascular spasm in the cardiomyopathic Syrian hamster: A preventable cause of focal myocardial necrosis. Circulation. 66:1982;342-345.
19. Sole M. J., Liu P. Viral myocarditis: A paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy. J. Am. Coll. Cardiol. 22:(Suppl A):1993;99a-105a.
20. Shanlin R. J., Sole M. J., Rahimifar M., Tator C. H., Factor S. M. Increased intracranial pressure elicits hypertension, increased sympathetic activity, electrocardiographic abnormalities and myocardial damage in rats. J. Am. Coll. Cardiol. 12:1988;727-736.
21. Sole M. J., Factor S. M. Hamster cardiomyopathy: A genetically-transmitted sympathetic dystrophy? Beamish R. E., Panagia V., Dhalla N. S. Pathogenesis of Stress Induced Heart Disease. 1985;34-43 Martinus Nijhoff Publishing, Boston.
22. Pandey, A. S.; Sole, M. J.; Floras, J. S.; Dawood, F.; Wen-hu, W.; Wee, L.; Liu, P. The role of sympathetic activity in murine myocarditis leading to the development of dilated cardiomyopathy. J. Am. Coll. Cardiol. Suppl 1: 132A-133A; 1995. (Abstract).
23. Torre-Amione G., Kapadia S., Lee J., Bies R. D., Lebovitz R., Mann D. L. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation. 92:1995;1487-1493.
24. Kelly R. A., Balligand J-L., Smith T. W. Nitric oxide and cardiac function. Circ. Res. 79:1996;363-380.
25. Bobba A., Giannattasio S., Pucci A., Lippolis R., Camaschella C., Marra E. Characterization of mitochondrial DNA in primary cardiomyopathies. Clin. Chim. Acta. 243:1995;181-189.
26. Loesser K. E., Kukreja R. C., Kazziha S. Y., Jesse R. L., Hess M. L. Oxidative damage to the myocardium: a fundamental mechanism of myocardial injury. Cardioscience. 2:1991;199-216.
27. Kaul N., Siveski-Iliskovic N., Hill M., Slezak J., Singal P. K. Free radicals and the heart. J. Pharmacol. Toxicol. Methods. 30:1993;55-67.
28. Li R-K., Shaikh N., Weisel R. D., Williams W. G., Mickle D. A. Oxyradical-induced antioxidant and lipid changes in cultured myocytes. Am. J. Physiol. 266:(Heart Circ. Physiol. 35):1994;H2204-H2211.
29. Li R-K., Cowan D. B., Mickle D. A. G., Weisel R. D., Burton G. W. Effect of vitamin E on human glutathione peroxidase (GSH-Px1) expression in cardiomyocytes. Free Rad. Biol. Med. 21:1996;419-426.
30. Romaschin A. D., Wilson G. J., Thomas U., Feitler D. A., Tumiati L., Mickle D. A. G. Subcellular distribution of peroxidized lipids in myocardial reperfusion injury. Am. J. Physiol. 259:(Heart Circ. Physiol. 28):1990;H116-H123.
31. Stadtman E. R. Metal ion-catalyzed oxidation of proteins: Biochemical and biological consequences. Free Rad. Biol. Med. 9:1990;315-325.
32. Davies K. J. A. Intracellular proteolytic systems may function as secondary antioxidant defences: An hypothesis. Free Rad. Biol. Med. 2:1986;155-173.
33. Rivett A. J. Preferential degradation of the oxidatively modified forms of glutamine synthase by intracellular proteases. J. Biol. Chem. 260:1985;300-305.
34. Blaustein A. S., Schine L., Brooks W. W., Fanburg B. L., Bing O. H. L. Influence of exogenously generated oxidant species on myocardial function. Am. J. Physiol. 250:(Heart Circ. Physiol. 19):1986;H595-H599.
35. Kaneko M., Matsumoto Y., Hayashi H., Kobayashi A., Yamazaki N. Oxygen free radicals and calcium homeostasis in the heart. Mol. Cell. Biochem. 139:1994;91-100.
36. McGowan A. J., Ruiz-Ruiz M. C., Gorman A. M., Lopez-Rivas A., Cotter T. G. Reactive oxygen intermediate(s) (ROI): common mediators of poly(ADP-ribose)polymerase (PARP) cleavage and apoptosis. FEBS Letters. 392:1996;299-303.